Transfer of CD4+CD45RBhigh T cells from normal donors to SCID/Rag-1, 2-deficient mice, which lack T and B cells, leads to the development of a TH1-mediated inflammatory bowel disease (IBD)-like syndrome characterized by extensive mononuclear cell infiltrates and epithelial cell hyperplasia. Because it is well known that B cells are also involved in a multitude of mechanistic pathways in human IBD, this study attempts to establish a new model of colitis in nude mice.
We transferred CD4+CD45RBhigh T cells into athymic nude mice, which lack thymus-dependent T cells but retain normal B cells, to establish and investigate a B cell-involving chronic colitis model. As a control, CD4+CD25− T cells were also used.
Mice reconstituted with CD4+CD45RBhigh but not CD4+CD25− T cells developed a wasting disease, with severe infiltrates of B cell aggregates as well as T cells, macrophages, and dendritic cells into the colon and elevated levels of interferon-γ, tumor necrosis factor-α, interleukin (IL)-4, IL-5, and IL-10, by 7 weeks after T cell transfer. Furthermore, the infiltrated lamina propria B cells in colitic nude mice consisted predominantly of massive aggregated immunoglobulin (Ig) M- and scattered IgG-positive cells, but not IgA-positive cells. In contrast, mice reconstituted with CD4+CD45RBhigh and CD4+CD45RBlow did not develop wasting disease or colitis.
Collectively, the power of the colitis model induced by the adoptive transfer of CD4+CD45RBhigh T cells into nude mice is that one can investigate the roles of TH2-type cells and B cells in a regulatory T cell-depleted condition.
1 Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo
2 Department of Gastroenterology, Research Institute, International Medical Center of Japan, Tokyo
*Reprints: Department of Gastroenterology and Hepatology, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
Received 10 September 2005; Accepted 9 November 2005
This study was supported in part by grants-in-aid for Scientific Research, Scientific Research on Priority Areas, Exploratory Research and Creative Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Grant sponsor: Japanese Ministry of Health, Labor and Welfare; Grant sponsor: Japan Medical Association; Foundation for Advancement of International Science; Grant sponsor: Yakult Bio-Science Foundation; Grant sponsor: Research Fund of the Mitsukoshi Health and Welfare Foundation; Grant sponsor: Okawa Intractable Disease Research Foundation; Grant sponsor: Ooyama Health Science Foundation; Grant sponsor: Japan Health Sciences Foundation.